Interferon (IFN)–γ–Inducible Protein–10: Association with Histological Results, Viral Kinetics, and Outcome during Treatment with Pegylated IFN‐α2a and Ribavirin for Chronic Hepatitis C Virus Infection
The Journal of Infectious Diseases2006Vol. 194(7), pp. 895–903
Citations Over TimeTop 10% of 2006 papers
Ana I. Romero, Martin Lagging, Johan Westin, Amar P. Dhillon, Lynn B. Dustin, Jean–Michel Pawlotsky, Avidan U. Neumann, Carlo Ferrari, Gabriele Missale, Bart L. Haagmans, Solko W. Schalm, Stefan Zeuzem, Francesco Negro, Elke Verheij‐Hart, Kristoffer Hellstrand, DITTO‐HCV Study Group
Abstract
Baseline IP-10 levels are predictive of the response to HCV treatment.
Related Papers
- → Pegylated interferon plus ribavirin versus non-pegylated interferon plus ribavirin for chronic hepatitis C(2005)5 cited
- → 576 Early detection of depressive symptoms during treatment with pegylated interferon α-2 and ribavirin in euthymic chronic hepatitis C patients(2006)
- → PA.104 PREDICTORS OF SUSTAINED VIROLOGICAL RESPONSE IN PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH PEGYLATED INTERFERON AND RIBAVIRIN(2008)
- → 907 IS SHORT TIME COMBINED THERAPY WITH PEGYLATED INTERFERON PLUS RIBAVIRIN EFFECTIVE IN PATIENTS WITH ACUTE HEPATITIS C?(2013)
- → Dermatological Side Effects in a Patient with Hepatitis C Infection During Treatment with Pegylated Interferon/Ribavirin+Telaprevir: A Case Report(2014)